BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26548904)

  • 1. Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer "The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Localized Disease".
    Lim B; Jiang Y
    Curr Clin Pharmacol; 2015; 10(4):267-78. PubMed ID: 26548904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant therapy for gastric cancer.
    Chadha MK; Kuvshinoff BW; Javle MM
    Oncology (Williston Park); 2005 Aug; 19(9):1219-27; discussion 1227-8, 1231-2. PubMed ID: 16255136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant and adjuvant approaches in gastroesophageal cancers.
    Scheck MK; Masetti M; Lorenzen S
    Curr Opin Oncol; 2023 Jul; 35(4):318-325. PubMed ID: 37222198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic esophagus and gastric cancer.
    Shah MA; Schwartz GK
    Semin Oncol; 2004 Aug; 31(4):574-87. PubMed ID: 15297948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for chemotherapy in cancers of the esophagus, stomach and pancreas].
    Haag C; Ehninger G
    Z Gastroenterol; 2002 Apr; 40 Suppl 1():S68-S70. PubMed ID: 11930294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative drugs and strategies in the treatment of upper gastrointestinal tract carcinomas.
    Menges M; Hoehler T
    Onkologie; 2004 Feb; 27(1):47-53. PubMed ID: 15007248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies.
    Kim S; Barzi A; Rajdev L
    Semin Oncol; 2018 Jun; 45(3):133-150. PubMed ID: 30262395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric Carcinoma at the Era of Targeted Therapies.
    Dreanic J; Dhooge M; Sion E; Brezault C; Chaussade S; Coriat R
    Curr Drug Targets; 2016; 17(15):1818-1826. PubMed ID: 25944013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape?
    Lee M; Gibbs P; Wong R
    Clin Colorectal Cancer; 2015 Dec; 14(4):251-61. PubMed ID: 26210575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative neoadjuvant chemotherapy in esophago-cardial adenocarcinoma?].
    Geissler M
    Dtsch Med Wochenschr; 2006 Jun; 131(23):1344. PubMed ID: 16761207
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastric and gastro-oesophageal cancer therapy.
    Das P; Ajani JA
    Expert Opin Pharmacother; 2005 Dec; 6(16):2805-12. PubMed ID: 16318431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies.
    Tomasello G; Petrelli F; Ghidini M; Pezzica E; Passalacqua R; Steccanella F; Turati L; Sgroi G; Barni S
    Eur J Surg Oncol; 2017 Sep; 43(9):1607-1616. PubMed ID: 28347525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific therapy for cancer of the oesophagus: a new 'cancer of the elderly'.
    Krasna MJ
    Drugs Aging; 2009; 26(3):185-94. PubMed ID: 19358615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel targeted therapies in the treatment of gastric and esophageal cancer.
    Tabernero J; Macarulla T; Ramos FJ; Baselga J
    Ann Oncol; 2005 Nov; 16(11):1740-8. PubMed ID: 15980157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.